On this basis, we hypothesize that lathyrol might suppress the proliferation of RCC cells by inhibiting expression of TGF-β/Smad signaling pathway components in RCC, affecting the function of the RCC cell cycle and thus exerting an antitumor effect. This evidence concerns the gene TGFB1 and renal cell carcinoma.